local_hospital

Centrul De Excelenta In Rinologie S.R.L.

Address
Strada Toporasi Nr 51 Parter, Block C2, 200222 Craiova, Romania

Centrul De Excelenta In Rinologie S.R.L. - Center of Excellence in Rhinology

The Center of Excellence in Rhinology is a specialized medical research facility dedicated to advancing the understanding and treatment of chronic rhinosinusitis and related sinonasal disorders. The center focuses on evaluating novel biologic therapies and innovative treatment approaches for patients with inadequately controlled rhinosinusitis conditions.

  • Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) - investigating targeted biologic therapies including lebrikizumab and itepekimab
  • Chronic Rhinosinusitis Without Nasal Polyps - proof of concept studies for anti-IL-33 monoclonal antibody treatments
  • Advanced rhinologic interventions combining intranasal corticosteroids with novel immunomodulatory agents

The research center participates in multiple Phase 3 clinical trials evaluating cutting-edge monoclonal antibody therapies targeting specific inflammatory pathways, including IL-33 inhibition. Their clinical studies focus on objective outcomes such as endoscopic nasal polyp scores, sinus opacification measurements, and patient-reported symptom severity, particularly nasal congestion. This comprehensive approach positions the center at the forefront of developing more effective therapeutic options for patients with difficult-to-treat respiratory tract diseases affecting the sinonasal cavity.

Site Overview

assignment
4
connected trials
corporate_fare
2
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
4
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
4
Outperforms 56% of sites
public
Therapeutic diversity
2areas
Outperforms 51% of sites
groups
Sponsor diversity
2sponsors
Outperforms 42% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrul De Excelenta In Rinologie S.R.L.

lock Showing 1 of 4 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Lebrikizumab in Chronic Rhinosinusitis with Nasal Polyps on Intranasal Corticosteroids: A Phase 3 Randomized Controlled TrialEli Lilly & Co.Phase IIIRecruitingOct 2024

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Itepekimab3Unknown2025-03-202026-06-23

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.